Generic Medicine Info
Special Precautions
Hepatic impairment.
Adverse Reactions
Diarrhoea, loose stools, headaches, rhinorrhoea.
Drug Interactions
May reduce absorption of drugs (e.g. ketoconazole) whose absorption is dependent on gastric pH.
Description: Revaprazan is a proton pump inhibitor that is currently being investigated for the management of gastric and duodenal ulceration, functional dyspepsia and GERD.
Absorption: Rapidly absorbed.
Excretion: Plasma half-life: 2.2-2.4 hr.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
Disclaimer: This information is independently developed by MIMS based on Revaprazan from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in